RAPP
Rapport Therapeutics Inc. (RAPP)
Market Closed
12 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
30. 30
+1.52
+5.28%
$
1.04B Market Cap
- P/E Ratio
0% Div Yield
225,751 Volume
- Eps
$ 28.78
Previous Close Day Range
28.03 30.5
Year Range
6.43 42.27
Want to track RAPP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 87 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| RAPP RAPP Rapport Therapeutics Inc. 10 Mar 2026 (In 2 months) | | - | - |
| RAPP RAPP Rapport Therapeutics Inc. 6 Nov 2025 | | - | - |
| RAPP RAPP Rapport Therapeutics Inc. 5 Nov 2025 | | - | - |
| RAPP RAPP Rapport Therapeutics Inc. 7 Aug 2025 | | - | - |
| RAPP RAPP Rapport Therapeutics Inc. 28 May 2025 | | - | - |
| RAPP RAPP Rapport Therapeutics Inc. 11 Mar 2025 | | - | - |
| RAPP RAPP Rapport Therapeutics Inc. 7 Nov 2024 | | - | - |
| RAPP RAPP Rapport Therapeutics Inc. 8 Aug 2024 | | - | - |
RAPP Earnings Reports FAQ
What is the earnings per share (EPS) for RAPP?
EPS data for RAPP is currently not available, as Rapport Therapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Rapport Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-10, based on the RAPP's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Rapport Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RAPP at this time, as Rapport Therapeutics Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
